Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Santa Monica, CA, May 23, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
-
Santa Monica, CA, May 21, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
-
Santa Monica, CA, May 20, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
-
San Diego, May 16, 2019 (GLOBE NEWSWIRE) -- The DIII-D National Fusion Program has completed a series of important enhancements to its fusion facility, providing researchers with several...
-
OAKVILLE, Ontario, May 15, 2019 (GLOBE NEWSWIRE) -- Terrestrial Energy today announced the addition of Ontario Power Generation to its Nuclear Innovation Working Group. The working group is advising...
-
SALT LAKE CITY, May 14, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in personalized medicine, today announced that it will present results from multiple studies at the...
-
Winston-Salem, NC, May 13, 2019 (GLOBE NEWSWIRE) -- WINSTON-SALEM, NC – The sixth annual Regenerative Medicine Essentials Course will be held June 10 - 14 in downtown Winston-Salem. The course is...
-
WARMINSTER, Pa., May 13, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr....
-
OAKVILLE, Ontario, May 13, 2019 (GLOBE NEWSWIRE) -- Terrestrial Energy has been admitted to the Generation IV International Forum (GIF), currently the only private sector company with this status....
-
SALT LAKE CITY, May 09, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that the EndoPredict® test (EPclin) identifies women...